Terrassa Sud Primary Care Center, Hospital Universitari Mutua Terrassa, University of Barcelona, Barcelona, Spain.
Fundació Docència i Recerca Mutua Terrassa, Barcelona, Spain.
Int J Chron Obstruct Pulmon Dis. 2020 Jun 18;15:1403-1413. doi: 10.2147/COPD.S250720. eCollection 2020.
The best criterion for diagnosing airway obstruction in COPD, fixed ratio (FR: FEV1/FVC<0.7) or lower limit of normality (LLN), remains controversial. We compared the long-term evolution of COPD patients according to the initial obstruction criteria.
Between 2005 and 2008, we evaluated 1728 subjects over 45 years of age with smoking history, pertaining to a primary care center. A total of 424 patients were obstructive by FR, after a bronchodilator test. Of those, 289 patients met obstruction criteria for both FR and LLN and were considered concordant patients (FR+LLN+), while 135 patients were obstructive by FR but non-obstructive by LLN and were defined as discordant patients (FR+LLN-).
Forty-eight patients (11.3%) were lost in follow-up, and 158 died (37.3%). After a median time of 120.4 months (IQR 25-75%: 110.2-128.8), 215 patients were spirometrically reevaluated. The annualized loss of FEV1/FVC was greater in discordant (FR+LLN-) patients [0.54 (0.8) vs 0.82 (0.7); p = 0.008], while 81% became concordant (FR+LLN+) during the follow-up. Hospitalization for COPD exacerbations was more frequent in concordant (FR+LLN+) patients (1.57±3.51 vs 0.77±2.29; p = 0.002). Adjusting for age, concordant (FR+LLN+) patients had greater COPD mortality (HR: 2.97; CI 95%: 1.27-7.3; p = 0.02).
LLN seems to be less useful for COPD diagnosis in primary care. Discordant (FR+LLN-) patients lost more FEV1/FVC during their evolution and tended to become concordant. LLN predicted COPD hospitalizations and mortality more poorly.
在 COPD 中,用于诊断气道阻塞的最佳标准,固定比值(FR:FEV1/FVC<0.7)或正常值下限(LLN)仍存在争议。我们比较了根据初始阻塞标准的 COPD 患者的长期演变。
在 2005 年至 2008 年间,我们评估了来自一个初级保健中心的 1728 名年龄在 45 岁以上的有吸烟史的患者。在支气管扩张剂测试后,共有 424 名患者通过 FR 被诊断为阻塞性疾病。其中,289 名患者的 FR 和 LLN 均符合阻塞性疾病标准,被认为是一致患者(FR+LLN+),而 135 名患者的 FR 符合阻塞性疾病标准但 LLN 不符合,被定义为不一致患者(FR+LLN-)。
48 名患者(11.3%)在随访中丢失,158 名患者死亡(37.3%)。在中位时间为 120.4 个月(IQR 25-75%:110.2-128.8)后,对 158 名患者进行了肺量计复查。不一致患者(FR+LLN-)的 FEV1/FVC 年损失更大[0.54(0.8)与 0.82(0.7);p=0.008],而在随访过程中,81%的患者成为一致患者(FR+LLN+)。一致患者(FR+LLN+)因 COPD 加重而住院的频率更高(1.57±3.51 与 0.77±2.29;p=0.002)。在校正年龄后,一致患者(FR+LLN+)的 COPD 死亡率更高(HR:2.97;95%CI:1.27-7.3;p=0.02)。
在初级保健中,LLN 似乎对 COPD 的诊断用处不大。不一致患者(FR+LLN-)在其演变过程中失去了更多的 FEV1/FVC,且往往变得一致。LLN 对 COPD 住院和死亡率的预测较差。